The cure or treatment plan for COVID-19 infection is under progress by scientists and researchers across the globe. The virus is again spreading at an exponential rate as it hits the peak number of cases during the second wave. European countries have imposed lockdowns once again, while some American states are also under lockdown.
The solution to bring lives back to normal is to find a suitable treatment strategy for the coronavirus infection. The COVID-19 infection treatment may be possible by using a vaccine, antibody therapy, or plasma therapy. Furthermore, a new finding suggests that Aspirin can be the first OTC drug for COVID-19 treatment. However, officially using it for coronavirus treatment requires further research.
Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) and belongs to Over-The-Counter-drugs (OTC). OTC drugs are those that can be given to the purchaser without an official prescription from the doctor and are safe to use. NSAIDs are drugs that function to reduce inflammation in the body.
Furthermore, people use it to relieve minor aches, pains, and fever. Moreover, Aspirin acts as a blood thinner for cardiovascular patients. The drug is capable of reducing swelling, relieving headaches, and reducing fever. Some doctors prescribe it to COVID-19 patients.
The analgesic, anti-inflammatory, and antiplatelet effects depend upon the dose regimen in which a patient takes the drug. The generic term for aspirin is acetylsalicylic acid. Aspirin can relieve mild to moderate pain associated with flu, sprains, strains, muscle cramps, and headaches. In severe pain, doctors prescribe it alongside other NSAID and opioid relievers. Aspirin is not efficacious for all cardiovascular patients.
However, low-doses of it are effective in patients with heart disease, hypertension, hypercholesterolemia, diabetes, and are persistent smokers. Health professionals prescribe acetylsalicylic acid to cardiovascular patients with COVID-19 infection.
Research on Aspirin For COVID-19 Patients
A new study suggests that taking aspirin daily at low-doses reduces the risk of death from COVID-19 infection. Dr. Jonathan Chow is an assistant professor of anesthesiology at the University of Maryland Medical School of Medicine (UMSOM). According to Dr. Jonathan Chow, their research suggests that if confirmed, acetylsalicylic-acid will be the first widely available OTC drug to reduce mortality in coronavirus patients.
For the study, the research team looked at the records of 412 COVID-19 patients. The patients were undergoing treatment at the University of Maryland Medical Center in Baltimore and three other hospitals along the East Coast.
About 25% of these patients were taking low doses of acetylsalicylic acid before or right after admittance to the hospital. Moreover, to manage their cardiovascular disease. Furthermore, researchers control several factors. These factors include sex, race, body-mass-index, and underlying conditions like hypertension and diabetes.
ALSO READ: COVID-19 A Viral Infection To Co-exist With
Effect Of Aspirin On COVID-19 Patients
The new research suggests that COVID-19 increases the risk of dangerous complications. Furthermore, it can cause clot formation in the heart, lungs, and blood vessels. Thus, aspirin blood-thinning action is very significant in COVID-19 patients.
According to Dr. Michael Mazzeffi, the blood-thinning activity of acetylsalicylic-acid is beneficial against coronavirus infection. Moreover, the results of research elaborate that acetylsalicylic-acid decreases the risk of dying in hospitalized cardiovascular patients with coronavirus infection. Furthermore, the decrease occurs by 47% as compared to those who were not taking Aspirin.
Also, the daily use of acetylsalicylic acid in low doses lowers the risk of ICU admission by 43 percent. Furthermore, the risk of being put on a mechanical ventilator decreases by 44 percent with the use of acetylsalicylic acid. However, COVID-19 patients must not take any drug without consulting the doctor.
The research team suggests that the drug does not protect against coronavirus. It still prevents the development of complications in coronavirus patients. However, doctors need more evidence to use acetylsalicylic acid in coronavirus patients.